This stable-labeled internal standard of teriflunomide is suitable for critical quantitative applications in clinical and diagnostic testing such as therapeutic drug monitoring assays. Teriflunomide, also known as Aubagio, is the active metabolite of leflunomide, an immunosuppressive disease-modifying antirheumatic drug, used in active moderate-to-severe rheumatoid arthritis and psoriatic arthritis.